Ranitidine drugs banned for six months
Low-level contamination with probable carcinogen to blame
9th January 2020
More than 100 brands, strengths and formulations of the heartburn medicine ranitidine will be banned in Australia for six months, the TGA has announced.
It follows revelations that at least some products contain the probable carcinogen N-nitrosodimethylamine (NDMA) — a problem first identified in the US and Europe last year.
In Australia, eight branded and generic tablets and liquids